ScyFIX is seeking to raise $4 million as the Chanhassen, Minnesota-based company continues to seek U.S. Food and Drug Administration approval for a device that uses slight electric shocks to treat ...
> ScyFIX is seeking to raise $4 million as the Chanhassen, MN-based company continues to seek FDA approval for a device that uses slight electric shocks to treat degenerative eye disease. Story > ...
ScyFix’s CEO Tom Harold says his company hopes to put the first Food and Drug Administration (FDA)-approved ophthalmic device for reversing symptoms of certain eye diseases on the market by summer.